Pharmaceutical Science and Clinical Pharmacology Advisory Committee Roster
Applying for Membership on FDA Advisory Committees
As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info
Chairperson (Pharmaceutical Science)
Kenneth R. Morris, MS, PhD
Expertise: Pharmaceutics
Term: 11/1/2018 – 10/31/2022
Director and Professor
Lachman Institute for Pharmaceutical Analysis
Long Island University, College of Pharmacy
75 Dekalb Avenue, L32
Brooklyn, New York 11201
Designated Federal Officer (Acting)
Rhea Bhatt, MS
Division of Advisory Committee and Consultant Management
Office of Executive Programs
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
Phone: (301) 796-9001 Fax: (301) 847-8533
E-mail: [email protected]
Chairperson (Clinical Pharmacology)
Walter K. Kraft, MD, MS, FACP
Expertise: Clinical Pharmacology and Internal Medicine
Term: 11/1/2018 – 10/31/2022
Professor of Pharmacology and Experimental Therapeutics
Thomas Jefferson University
132 S. 10th Street, 1170 Main Building
Philadelphia, Pennsylvania 19107
Paul M. Beringer, PharmD
Expertise: Clinical Pharmacology
Term: 11/1/2018 – 10/31/2022
Professor and Chair, Department of Clinical Pharmacy
University of Southern California, School of Pharmacy
1985 Zonal Avenue, B15E
Los Angeles, California 90089
Jeffery M. Carrico, PharmD, BCPS
Expertise: Clinical Research/Clinical Pharmacology/Human Subjects Protection
Term: 12/30/2015 – 10/31/2022
Service Chief, Clinical Pharmacy and Investigational Drug Research
Member, Institutional Review Board (IRB)
National Institutes of Health (NIH), Clinical Center
Bethesda, Maryland 20892
*Sandra Finestone, PsyD
Expertise: Consumer Representative
Term: 11/1/2017 – 10/31/2025
Executive Director
Association of Cancer Patient Educators
18025 Sky Park Circle, Suite A
Irvine, California 92614
Leonid Kagan, PhD
Expertise: Pharmacokinetics
Term: 11/1/2021 to 10/31/2025
Associate Professor
Department of Pharmaceutics, Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
160 Frelinghuysen Road
Piscataway, New Jersey 08854
Arthur H. Kibbe, PhD
Expertise: Excipients, Formulation and Pharmacokinetics
Term: 1/23/2020 – 10/31/2023
Emeritus Professor
Wilkes University, Nesbitt School of Pharmacy
84 West South Street
Wilkes-Barre, Pennsylvania 18766
Kelvin H. Lee, PhD
Expertise: Biopharmaceutical Development and Science
Term: 1/23/2020 – 10/31/2023
Gore Professor, Chemical & Biomolecular Engineering
University of Delaware
590 Avenue 1743
Newark, Delaware 19713
Frances J. Richmond, MSc, PhD
Expertise: Regulatory Science
Term: 9/27/2018 – 10/31/2025
Professor and Director
D K Kim International Center for Regulatory Science
1540 Alcazar Street
Los Angeles, California 90089
**Mark C. Rogge, PhD
Expertise: Translational Science, Biotechnology
Term: 11/1/2019 – 10/31/2023
Research Professor
Center for Pharmacometrics and Systems Pharmacology
University of Florida
6550 Sanger Road, Office 465
Orlando, Florida 32827-7400
**Pravin Rothe, MPharm
Expertise: Validation and Technology Transfer
Term: 11/1/2019 – 10/31/2023
Validation Lead, Manufacturing Sciences and Technology
Novartis
4700 Sandoz Drive
Wilson, North Carolina 27893
Eric V. Slud, PhD
Expertise: Mathematical Statistics
Term: 3/8/2019 – 10/31/2025
Area Chief for Mathematical Statistics
Center for Statistical Research and Methodology
Census Bureau
4600 Silver Hill Road
Washington, D.C. 20233
**T.G. Venkateshwaran, PhD
Expertise: Pharmaceutical Sciences
Term: 11/1/2019 – 10/31/2023
Associate Vice President and Global Head
Global Regulatory Affairs – CMC Biologics and Combination Products
Merck Research Laboratories, Ltd.
770 Sumneytown Pike
West Point, Pennsylvania 19486
* Consumer Representative
** Industry Representative (non voting)